Table 3.
Sleep data for baseline and test nights in Val/Val and Met carriers (mean ± SD)
(min) | Baseline night |
Test night |
Statistics for allelic group difference | ||
---|---|---|---|---|---|
Val/Val (n = 14) | Met carriers (n = 15) | Val/Val (n = 14) | Met carriers (n = 15) | ||
Stage 2 duration | 179.1 ± 27.9 | 188.4 ± 34.7 | 187.7 ± 25.4 | 179.8 ± 36.8 | F(1,21) = 0.00, p = 0.96 |
Stage 3 duration | 169.3 ± 34 | 164.7 ± 45.4 | 161 ± 15.4 | 167.8 ± 41 | F(1,21) = 0.15, p = 0.71 |
REM duration | 98.3 ± 21.3 | 103.3 ± 22.6 | 102.2 ± 28.9 | 119.7 ± 14.7 | F(1,21) = 2.53, p = 0.13 |
Stage 2 latency | 8.9 ± 6.3 | 12.4 ± 11.5 | 12.4 ± 11.2 | 12.3 ± 10.4 | F(1,27) = 0.32, p = 0.58 |
Stage 3 latency | 15.3 ± 7.3 | 19.5 ± 13.6 | 15.9 ± 11.5 | 17.4 ± 10.6 | F(1,27) = 0.73, p = 0.40 |
REM latency | 117.8 ± 54.9 | 95 ± 13.6 | 85.1 ± 24.8 | 88.8 ± 38.3 | F(1,27) = 0.60, p = 0.43 |
Total time in bed | 494.5 ± 13.6 | 497.1 ± 12.7 | 503.3 ± 5.7 | 505.3 ± 10.1 | F(1,27) = 0.18, p = 0.68 |
Sleep duration | 446.7 ± 31 | 456.4 ± 22.7 | 451 ± 38.2 | 467.3 ± 23.1 | F(1,21) = 3.11, p = 0.09 |
First NREM period | |||||
Stage 2 duration | 15 ± 15 | 15.4 ± 11.3 | 9.6 ± 5.0 | 9.7 ± 4.6 | F(1,27) = 0.00, p = 0.95 |
Stage 3 duration | 57.5 ± 15.1 | 51.5 ± 16.4 | 56.7 ± 15.0 | 48.2 ± 10.4 | F(1,27) = 3.73, p = 0.06 |
Total period duration | 81.9 ± 33.6 | 69.4 ± 17.5 | 67.2 ± 17.3 | 58.4 ± 10.9 | F(1,27) = 2.61, p = 0.12 |
Q1 | |||||
Stage 2 duration | 6.6 ± 3.9 | 6.2 ± 2.7 | 5 ± 1.7 | 5.7 ± 1.7 | F(1,27) = 0.08, p = 0.78 |
Stage 3 duration | 11.7 ± 6.3 | 10.9 ± 5.2 | 11.9 ± 4.1 | 9.2 ± 5.1 | F(1,27) = 1.45, p = 0.24 |
Total period duration | 21.9 ± 8.7 | 17.5 ± 4.3 | 16.9 ± 4.3 | 15.2 ± 4.5 | F(1,27) = 3.13, p = 0.09 |